Dr. Michael A. Schmidt, President and Chief Scientific Officer of Sovaris Aerospace, will lecture at the European Society for Translational Medicine (EUSTM) Symposium on September 2, 2015. Dr. Schmidt’s group is focused on assessing the biological, biochemical, and physiologic demands placed on human and biological systems in the complexity of space.The presentation is entitled, “Space Flight Omics and their Relation to Translational Medicine on Earth.”
The presentation abstract appears below:
“Space flight is one of the most extreme conditions encountered by humans. Advances in Omics methodologies (genomics, epigenomics, transcriptomics, proteomics, and metabolomics) have revealed that unique differences exist between individuals. These differences can be amplified in extreme conditions, such as space flight. In this session, we explore the role of targeted and untargeted omics in describing how converging variables can aggregate across molecular networks to affect astronaut health, safety, and performance on space exploration missions. We further explore how integrated omics can be used to accelerate discovery of space-based countermeasures for missions with short timelines, such as the first human mission to Mars in 2022. This includes an examination of how such personalized measures are relevant before, during, and after space missions. We finally explore how these findings may be translated to earth-based discovery and medical practice.”
Dr. Schmidt is also a member of the EUSTM Omics Applications Expert Panel and will be a part of panel discussions on Omics applications in translational medicine.